These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 22102057)

  • 1. Type-I IFN drives the differentiation of short-lived effector CD8+ T cells in vivo.
    Wiesel M; Crouse J; Bedenikovic G; Sutherland A; Joller N; Oxenius A
    Eur J Immunol; 2012 Feb; 42(2):320-9. PubMed ID: 22102057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effector T-cell differentiation during viral and bacterial infections: Role of direct IL-12 signals for cell fate decision of CD8(+) T cells.
    Keppler SJ; Theil K; Vucikuja S; Aichele P
    Eur J Immunol; 2009 Jul; 39(7):1774-83. PubMed ID: 19548244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I IFN substitutes for T cell help during viral infections.
    Wiesel M; Kratky W; Oxenius A
    J Immunol; 2011 Jan; 186(2):754-63. PubMed ID: 21160039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of CD80/CD86 in generation and maintenance of functional virus-specific CD8+ T cells in mice infected with lymphocytic choriomeningitis virus.
    Grujic M; Bartholdy C; Remy M; Pinschewer DD; Christensen JP; Thomsen AR
    J Immunol; 2010 Aug; 185(3):1730-43. PubMed ID: 20601595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-specific activation thresholds of CD8+ T cells are independent of IFN-I-mediated partial lymphocyte activation.
    Wijesundara DK; Kumar S; Alsharifi M; Müllbacher A; Regner M
    Int Immunol; 2010 Sep; 22(9):757-67. PubMed ID: 20682547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung.
    Chen HD; Fraire AE; Joris I; Brehm MA; Welsh RM; Selin LK
    Nat Immunol; 2001 Nov; 2(11):1067-76. PubMed ID: 11668342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells.
    Kaech SM; Tan JT; Wherry EJ; Konieczny BT; Surh CD; Ahmed R
    Nat Immunol; 2003 Dec; 4(12):1191-8. PubMed ID: 14625547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitatively different memory CD8+ T cells are generated after lymphocytic choriomeningitis virus and influenza virus infections.
    Mueller SN; Langley WA; Li G; García-Sastre A; Webby RJ; Ahmed R
    J Immunol; 2010 Aug; 185(4):2182-90. PubMed ID: 20639484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective delivery of augmented IL-2 receptor signals to responding CD8+ T cells increases the size of the acute antiviral response and of the resulting memory T cell pool.
    Cheng LE; Greenberg PD
    J Immunol; 2002 Nov; 169(9):4990-7. PubMed ID: 12391213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections.
    Bahl K; Kim SK; Calcagno C; Ghersi D; Puzone R; Celada F; Selin LK; Welsh RM
    J Immunol; 2006 Apr; 176(7):4284-95. PubMed ID: 16547266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.
    Prévost-Blondel A; Zimmermann C; Stemmer C; Kulmburg P; Rosenthal FM; Pircher H
    J Immunol; 1998 Sep; 161(5):2187-94. PubMed ID: 9725210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the transduction of canonical Wnt signals demarcate effector and memory CD8 T cells with distinct recall proliferation capacity.
    Boudousquié C; Danilo M; Pousse L; Jeevan-Raj B; Angelov GS; Chennupati V; Zehn D; Held W
    J Immunol; 2014 Sep; 193(6):2784-91. PubMed ID: 25127860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cells.
    Belnoue E; Fontannaz-Bozzotti P; Grillet S; Lambert PH; Siegrist CA
    J Virol; 2007 Jul; 81(14):7338-50. PubMed ID: 17494081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homeostatic regulation of CD8+ T cells after antigen challenge in the absence of Fas (CD95).
    Zimmermann C; Rawiel M; Blaser C; Kaufmann M; Pircher H
    Eur J Immunol; 1996 Dec; 26(12):2903-10. PubMed ID: 8977284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections.
    Brehm MA; Markees TG; Daniels KA; Greiner DL; Rossini AA; Welsh RM
    J Immunol; 2003 Apr; 170(8):4077-86. PubMed ID: 12682237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8alphaalpha-mediated survival and differentiation of CD8 memory T cell precursors.
    Madakamutil LT; Christen U; Lena CJ; Wang-Zhu Y; Attinger A; Sundarrajan M; Ellmeier W; von Herrath MG; Jensen P; Littman DR; Cheroutre H
    Science; 2004 Apr; 304(5670):590-3. PubMed ID: 15105501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting edge: CCR7+ and CCR7- memory T cells do not differ in immediate effector cell function.
    Unsoeld H; Krautwald S; Voehringer D; Kunzendorf U; Pircher H
    J Immunol; 2002 Jul; 169(2):638-41. PubMed ID: 12097363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive expression of Bcl-xL or Bcl-2 prevents peptide antigen-induced T cell deletion but does not influence T cell homeostasis after a viral infection.
    Petschner F; Zimmerman C; Strasser A; Grillot D; Nunez G; Pircher H
    Eur J Immunol; 1998 Feb; 28(2):560-9. PubMed ID: 9521066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T Cell factor 1 represses CD8+ effector T cell formation and function.
    Tiemessen MM; Baert MR; Kok L; van Eggermond MC; van den Elsen PJ; Arens R; Staal FJ
    J Immunol; 2014 Dec; 193(11):5480-7. PubMed ID: 25355919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IRF9 Prevents CD8
    Huber M; Suprunenko T; Ashhurst T; Marbach F; Raifer H; Wolff S; Strecker T; Viengkhou B; Jung SR; Obermann HL; Bauer S; Xu HC; Lang PA; Tom A; Lang KS; King NJC; Campbell IL; Hofer MJ
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.